Priavoid started the first-in-human, first-in-class phase I-study of PRI-002 on April 16th 2018. A Phase II clinical trial is in preparation and scheduled to start in 2019.

News from March 20th, 2018 at 07 p.m. by German radio station WDR.

von WDR akuell

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help.

Select an option to continue

Your selection was saved!



To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set.

You can change your cookie setting here anytime: Privacy Policy. Legal Notice